In this cohort, increased CDC6 expression predicted metastasis (p = 7.41e-04), and was also prominently associated with prostate cancer-specific mortality (p = 1.09e-02, Supplementary Figure 5). The gene discussed is CDC6; the disease is prostate carcinoma.